This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.
Eperythrozoonosis is the older disease name
Mycoplasma suis was historically called Eperythrozoon suis, and the associated disease is still referred to as porcine eperythrozoonosis or infectious anemia of pigs. It is a hemoplasma associated with red blood cells, rather than a respiratory mycoplasma such as M hyopneumoniae.
Merck Veterinary Manual's July 2026 account explains the blood-cell association and pig-specific clinical effects. Red-cell injury and removal can reduce oxygen-carrying capacity, producing weakness and intolerance of exertion.
The presence of infection does not guarantee clinically important anemia. Some pigs carry the organism without clear signs. A useful diagnosis needs to explain what is harming the animal now rather than assume every positive result is an acute disease episode.
Acute anemia can make a pig pale and weak
Affected pigs may have fever, reduced appetite, pallor, restlessness or marked weakness. Jaundice can develop with hemolysis, while some pigs have bluish discoloration of the extremities. These findings are important but not uniquely diagnostic.
Severe weakness, collapse, difficult breathing or inability to stand requires urgent veterinary assessment. Minimize exertion and rough handling because a profoundly anemic pig has limited capacity to meet increased oxygen demand.
Provide comfortable resting space and accessible clean water and appropriate feed to pigs able to swallow normally. Do not force oral treatments into a collapsed or poorly responsive animal. Severe anemia may require more intensive support than a feed additive or routine injection can provide.
Chronic disease may be less obvious
The University of Minnesota pig-specific reference describes unthrifty or pale animals and the possibility of impaired reproductive and lactational performance. Merck likewise recognizes chronic growth and reproductive consequences.
These are nonspecific production findings. Poor growth or milk output alone does not establish M suis, and other nutritional, infectious or environmental problems may be present. A sow with a postpartum illness needs assessment for those alternatives as well.
Around farrowing, weakness or poor intake in the sow can also affect her piglets indirectly through reduced milk availability. Assess the sow and litter together without assuming that every poorly growing piglet is itself an acute hemoplasma case.
Other causes of anemia require a different response
Blood loss from gastric ulceration, heavy whipworm infection and iron deficiency are relevant alternatives. Hemolytic disease of newborns, including neonatal isoerythrolysis, has another mechanism.
The veterinarian distinguishes blood loss, reduced red-cell production and hemolysis using the clinical examination and laboratory findings. A pale pig does not automatically need more iron, and an iron product does not eliminate M suis.
Similarly, a positive M suis test does not exclude a bleeding ulcer. The degree of anemia, signs of blood loss and other findings determine whether more than one problem needs treatment.
A negative blood smear can miss infection
Organisms may be visible on red cells in a professionally prepared smear, but microscopy has important sensitivity limits. Low or fluctuating organism numbers and specimen conditions affect recognition. Stain material can also complicate interpretation.
A primary French diagnostic comparison found that many qPCR-positive blood samples were not positive by smear examination. This directly supports caution against using a negative smear as definitive exclusion. It does not mean that every qPCR assay is perfect or that a positive result proves the cause of anemia.
Specific molecular testing should be interpreted with blood counts and the pig's condition. The veterinarian and laboratory select suitable specimens and assess whether prior treatment or timing affects the result. Owners should not attempt blood collection or home microscopy.
Blood transfer is a practical prevention concern
Hemoplasmas can be transmitted through infected blood on needles, instruments or other equipment. Blood-feeding arthropods may also contribute, and vertical transmission has been reported in pigs. Avoid assuming that a respiratory mycoplasma prevention program covers these pathways.
Use an appropriate veterinary plan for injection and procedure hygiene and management of ectoparasites. Do not share blood-contaminated equipment between pigs. These actions reduce an avoidable pathway without claiming that every farm outbreak has one proven source.
The biosecurity collection gives broader source and equipment context. Preventing concurrent disease and unnecessary stress also helps the herd maintain resilience while the specific infection is assessed.
Treatment can improve illness without guaranteeing clearance
A veterinarian may use an appropriate antimicrobial and supportive care. Product selection must account for food-pig use and current permitted practice. Treatment of clinical disease and elimination of a carrier state are different goals.
Do not assume that improved color or appetite means the organism has been eradicated. Follow-up should assess red-cell recovery and clinical function as well as whether continued infection remains relevant. Persistent or recurrent anemia calls for reassessment of the cause and the possibility of another contributor.
Medicines used for feline infectious anemia are not a pig treatment recipe. Cat-specific doses, steroids or other protocols should not be transferred from a multispecies reference into farm-pig care.
Recovery should restore comfortable function
Observe whether the pig can move without exhausting itself, obtain feed and water and rejoin normal activity without distress. A recovering sow should also be assessed for effective lactation and ability to care for the litter.
Profound irreversible compromise may require euthanasia. The decision should reflect the animal's welfare and realistic response to treatment rather than persistence with repeated unselected products.
The pig reference and linked anemia differentials provide supporting information. Combining clinical assessment with appropriate molecular and hematological testing makes the result useful to the actual animal rather than simply attaching an organism name to pallor.
Does a negative smear rule out M suis?
No. Primary diagnostic research demonstrates that microscopy can miss qPCR-positive samples.
Is this the same infection as enzootic pneumonia?
No. M suis is blood-associated; M hyopneumoniae causes a different respiratory disease.
Cite this reference
LivestockDefense. “Mycoplasma suis in pigs: infectious anemia and diagnostic limits.” Updated 2026-11-02. https://livestockdefense.com/threats/mycoplasma-suis-infection-pigs/
Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.
How to cite a page and its revision ↗Sources & boundaries
Read the evidence in context.
These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.
- Merck Veterinary Manual: Hemotropic Mycoplasma infections in animals
Source update: 2026-07. Most recent check: 2026-11-02.
Pig-specific M suis disease, general blood-transfer transmission and diagnostic limitations. Cat/dog treatment doses and prognosis are not extrapolated to pigs.
- Normand and colleagues / Porcine Health Management: Comparison of qPCR and blood smear microscopy for the diagnosis of Mycoplasma suis in a French veterinary practice
Source update: 2020-02-20. Most recent check: 2026-11-02.
Primary diagnostic comparison supports lower smear sensitivity than qPCR in the studied sample set, not perfect accuracy for every assay or automatic clinical causation.
- University of Minnesota Swine Diseases: Mycoplasma suis
Source update: Not provided. Most recent check: 2026-11-02.
Pig-specific anemia, differential causes and treatment limitations; historical assay-availability statements not treated as current laboratory availability.
